Julian Robertson‘s Tiger Management has reported a large reduction in its holding of Enzymotec Ltd (NASDAQ:ENZY) in an amended filing with the Securities and Exchange Commission. Whereas the fund held more than 1.14 million shares of Enzymotec at the end of the first quarter, it now holds just 577,407 shares, which account for roughly 2.5% of the company’s common stock.
A biotechnology company based in Israel, Enzymotec Ltd (NASDAQ:ENZY) is a manufacturer and global distributor of bio-functional lipid ingredients and final products. So far this year, the stock has not been in a clear trend but has still managed to depreciate by roughly 8.6%. Shares are currently trading at a trailing Price to Earnings (P/E) ratio of 31, significantly lower than the industry average of 166, as reported by Yahoo! Finance. Enzymotec reported first quarter results on May 19, surpassing Wall Street’s expectations. Revenues came in at $14 million and the company registered adjusted earnings of $0.09 per share, topping analysts’ estimates of $0.05 per share.
At the end of the first quarter, approximately 35% of Enzymotec Ltd (NASDAQ:ENZY)’s outstanding stock was held by 6 elite hedge funds, unchanged during the quarter. Billionaire John Paulson is also betting on this stock, with his fund, Paulson & Co, having reported ownership of 4.22 million shares in its latest 13F filing. Jacob Gottlieb‘s Visium Asset Management also has Enzymotec in its equity portfolio, holding exactly 2.2 million shares according to its most recent 13F filing.
You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Tiger Partners Trading | 0 | 577,407 | 0 | 577,407 | 577,407 | 2.5% |
Tiger Partners | 0 | 577,407 | 0 | 577,407 | 577,407 | 2.5% |
Tiger Partners GP | 0 | 577,407 | 0 | 577,407 | 577,407 | 2.5% |
Tiger Management | 0 | 577,407 | 0 | 577,407 | 577,407 | 2.5% |
The Julian H. Robertson, Jr. Revocable Trust | 0 | 577,407 | 0 | 577,407 | 577,407 | 2.5% |
Julian H. Robertson, Jr | 0 | 577,407 | 0 | 577,407 | 577,407 | 2.5% |
Follow Julian Robertson's Tiger Management
Page 1 of 12 – SEC Filing
Enzymotec Ltd. |
(Name of Issuer) |
Ordinary Shares, par value NIS 0.01 per share |
(Title of Class of Securities) |
M4059L101 |
(CUSIP Number) |
July 1, 2016 |
(Date of Event Which Requires Filing of this Statement) |